Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Diphtheria
2024
2003
Clear all
Type of publications
NITAG documentation
(3)
Topics
Regions
Americas
(3)
Countries
Canada
(1)
United States of America
(2)
Diseases
COVID-19
(1)
Diphtheria
(2)
Meningococcal disease
(1)
Smallpox
(4)
Publication date
2024
(1)
2003
(2)
2023
(163)
2022
(609)
2021
(397)
2020
(218)
2019
(4)
2018
(5)
2017
(9)
2016
(11)
2015
(2)
2014
(4)
2013
(2)
2011
(5)
2010
(4)
2009
(2)
2008
(1)
2002
(1)
2000
(1)
1997
(1)
Target population
Older adults
(1)
Available to download in languages
English (EN)
(3)
3 results found
2024
∙
NACI
Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19
2003
FDA Approval of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, (INFANRIX®) for Fifth Consecutive DTaP Vaccine Dose
2003
FDA Licensure of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), and Poliovirus Vaccine Combined, (PEDIARIX™) for Use in Infants
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register